Ranolazine-d8 dihydrochloride

CAS: 1219802-60-4

Ref. 3D-UYB80260

Produktinformation

• Name: Ranolazine-d8 dihydrochloride

Beschreibung

Ranolazine-d8 dihydrochloride is a drug product that has been approved for the treatment of angina pectoris. Ranolazine is a drug that belongs to the class of antianginal drugs. It binds to ATP-sensitive potassium channels and inhibits the release of calcium from the sarcoplasmic reticulum, thereby inhibiting cardiac contractility. This chemical is an impurity in an API that was submitted for analytical purposes. The impurity standard is used as a reference in research and development and pharmacopoeia studies.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 508.50 g/mol
• Formel: C₂₄H₃₅Cl₂N₃O₄
• Reinheit: Min. 95%